Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 986427, 8 pages
http://dx.doi.org/10.1155/2012/986427
Research Article

Combining ZHENG Theory and High-Throughput Expression Data to Predict New Effects of Chinese Herbal Formulae

1College of Life Science and Biotechnology, Shanghai Jiaotong University, 800 Dongchuan Road, Shanghai 200240, China
2Research Center for Complex System of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China
3Key Lab of Systems Biology/Key Laboratory of Synthetic Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China

Received 10 January 2012; Accepted 9 March 2012

Academic Editor: Shao Li

Copyright © 2012 Shuhao Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. P. Lu and K. J. Chen, “Integrative medicine in clinical practice: from pattern differentiation in traditional Chinese medicine to disease treatment,” Chinese Journal of Integrative Medicine, vol. 15, no. 2, p. 152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Lu, C. Xiao, G. Chen et al., “Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine: distinct molecular signatures indentified by microarray expression profiles in CD4-positive T cell,” Rheumatology International, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Xiao, L. H. Zhao, and C. Lu, “Study on the differential gene expression of peripheral CD4+ among rheumatoid arthritis patients of cold or heat syndrome type with or without rheumatoid factor,” Zhongguo Zhong xi yi jie he Za Zhi, vol. 26, no. 8, pp. 689–693, 2006. View at Google Scholar · View at Scopus
  4. S. H. Wu, J. F. Sun, and S. Z. Guo, “Effect of compound recipe Gengniankang (Chinese characters) on senile sexual hormone and expression of estrogen receptor in bone of climacteric female rats,” Chinese Journal of Integrative Medicine, vol. 11, no. 3, pp. 205–208, 2005. View at Google Scholar · View at Scopus
  5. F. Zuo, Z. M. Zhou, M. Z. Yan et al., “Metabolism of constituents in Huangqin-Tang, a prescription in traditional Chinese medicine, by human intestinal flora,” Biological and Pharmaceutical Bulletin, vol. 25, no. 5, pp. 558–563, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Cao, Q. H. Xia, H. Meng, and A. P. Zhong, “Pharmacological effects of serum containing Chinese medicine Bushen Huayu Jiedu compound recipe in lung cancer drug-resistance cells,” Chinese Journal of Integrative Medicine, vol. 14, no. 1, pp. 46–50, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. T. Wang, Q. R. Tan, L. L. Sun et al., “Possible therapeutic effect of a Traditional Chinese Medicine, Sinisan, on chronic restraint stress related disorders,” Neuroscience Letters, vol. 449, no. 3, pp. 215–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Tanaka and S. Sawamura, “Therapeutic effect of a traditional Chinese medicine, ren-shen-yang-rong- tang (Japanese name: Ninjin'yoeito) on nitric oxide-mediated lung injury in a mouse infected with murine cytomegalovirus,” International Immunopharmacology, vol. 6, no. 4, pp. 678–685, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Li, B. Zhang, D. Jiang, Y. Wei, and N. Zhang, “Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae,” BMC Bioinformatics, vol. 11, supplement 11, p. S6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Li, B. Zhang, and N. Zhang, “Network target for screening synergistic drug combinations with application to traditional Chinese medicine,” BMC Systems Biology, vol. 5, supplement 1, p. S10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Li, Z. Q. Zhang, L. J. Wu, X. G. Zhang, Y. D. Li, and Y. Y. Wang, “Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network,” IET Systems Biology, vol. 1, no. 1, pp. 51–60, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Z. Miao, X. Z. Liang, and Y. H. Wang, “Clinical observation on treatment of diabetic peripheral neuropathy with qi-supplementing and blood-activating therapy,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 23, no. 11, pp. 826–828, 2003. View at Google Scholar
  13. H. F. Que, Y. Y. Zhu, Y. F. Wang et al., “Effects of Chinese herbs for replenishing qi and resolving stagnation on hypoxia-inducible factor-1α and vascular endothelial growth factor in granulation tissue of skin ulcers in rats with diabetes,” Journal of Chinese Integrative Medicine, vol. 5, no. 2, pp. 165–169, 2007. View at Google Scholar · View at Scopus
  14. L. M. Xu and Y. Y. Hu, “Studies on treatment of fatty liver with traditional Chinese medicine,” Zhong xi yi Jie He Xue Bao, vol. 1, no. 2, pp. 138–141, 2003. View at Google Scholar · View at Scopus
  15. X. Duan, D. Yang, and X. Sun, “Effect of yimai jiangya extract on plasma neuropeptide Y level in patients of senile hypertension with qi-deficiency and blood stasis syndrome,” Zhongguo Zhong xi yi Jie he Za Zhi, vol. 20, no. 10, pp. 750–752, 2000. View at Google Scholar · View at Scopus
  16. Q. Zhang, P. Liu, and H. W. Zhang, “Study on the patterns of TCM syndrome differentiation of 900 patients with posthepatitic cirrhosis,” Zhongguo Zhong xi yi jie he Za Zhi, vol. 26, no. 8, pp. 694–697, 2006. View at Google Scholar · View at Scopus
  17. C. Liu, Y. Hu, L. Xu, and P. Liu, “Effect of Fuzheng Huayu formula and its actions against liver fibrosis,” Chinese Medicine, vol. 4, p. 12, 2009. View at Publisher · View at Google Scholar
  18. J. Lamb, E. D. Crawford, D. Peck et al., “The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease,” Science, vol. 313, no. 5795, pp. 1929–1935, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Wei, D. Twomey, J. Lamb et al., “Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance,” Cancer Cell, vol. 10, no. 4, pp. 331–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. L. Smalley, T. W. Gant, and S. D. Zhang, “Application of connectivity mapping in predictive toxicology based on gene-expression similarity,” Toxicology, vol. 268, no. 3, pp. 143–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Tian, S. A. Greenberg, S. W. Kong, J. Altschuler, I. S. Kohane, and P. J. Park, “Discovering statistically significant pathways in expression profiling studies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 38, pp. 13544–13549, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Li, P. Hao, S. Zheng et al., “Gene expression module-based chemical function similarity search,” Nucleic Acids Research, vol. 36, no. 20, p. e137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. F. S. Larsen, B. Vainer, M. Eefsen, P. N. Bjerring, and B. A. Hansen, “Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis,” World Journal of Gastroenterology, vol. 13, no. 23, pp. 3232–3236, 2007. View at Google Scholar · View at Scopus
  24. E. Patsenker, V. Schneider, M. Ledermann et al., “Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis,” Journal of Hepatology, vol. 55, no. 2, pp. 388–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Bergman and M. Parkes, “Systematic review: the use of mesalazine in inflammatory bowel disease,” Alimentary Pharmacology and Therapeutics, vol. 23, no. 7, pp. 841–855, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. W. El-Andere, A. C. Lerario, and B. L. Wajchenberg, “Effect of short- and long-term chlorpropamide therapy on oral glucose tolerance and erythrocyte insulin receptors in non-obese non-insulin dependent diabetes mellitus,” Hormone and Metabolic Research, vol. 19, no. 6, pp. 257–263, 1987. View at Google Scholar · View at Scopus
  27. E. Fidan, H. Onder Ersoz, M. Yilmaz et al., “The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus,” Acta Diabetologica, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Bergson, G. Lipkind, S. P. Lee, M. E. Duban, and D. A. Hanck, “Verapamil block of T-type calcium channels,” Molecular Pharmacology, vol. 79, no. 3, pp. 411–419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. A. Santilli, A. C. Scotese, and R. M. Tomarelli, “A potent antihypercholesterolemic agent: [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14643),” Experientia, vol. 30, no. 10, pp. 1110–1111, 1974. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Chen, W. An, and J. Chu, “Effect of water extract of Poria on cytosolic free calcium concentration in brain nerve cells of neonatal rats,” Zhongguo zhong xi yi Jie he Za Zhi, vol. 18, no. 5, pp. 293–295, 1998. View at Google Scholar · View at Scopus
  31. H. Y. Fu and Y. Z. He, “Studies on the hidropoiesis of the decoction of gui-zhi tang in mice and rats,” Zhong xi yi Jie he Za Zhi, vol. 11, no. 1, pp. 34–6, 1991. View at Google Scholar · View at Scopus
  32. J. S. Lee, “Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats,” Life Sciences, vol. 79, no. 16, pp. 1578–1584, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Nogowski, P. Mackowiak, K. Kandulska, T. Szkudelski, and K. W. Nowak, “Genistein-induced changes in lipid metabolism of ovariectomized rats,” Annals of Nutrition and Metabolism, vol. 42, no. 6, pp. 360–366, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Si and D. Liu, “Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats,” Journal of Nutrition, vol. 138, no. 2, pp. 297–304, 2008. View at Google Scholar · View at Scopus
  35. G. Ji, Q. Yang, J. Hao et al., “Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms,” International Immunopharmacology, vol. 11, no. 6, pp. 762–768, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Q. Zhao, H. T. Gu, Y. Cheng, and A. et, “Applying Fuzheng Huayu Gantang comprehensive therapeutic program for treatment of post-hepatitis B liver cirrhosis complicated with glyco-metabolic abnormality,” Zhongguo zhong xi yi Jie he Za Zhi, vol. 28, no. 1, pp. 24–27, 2008. View at Google Scholar · View at Scopus